Decode Health secures $1.9 million NIH Phase II SBIR award for its AI-driven multiple sclerosis biomarker program, advancing research in collaboration with Circular Genomics.
Amount Raised
$1.9 Million
Round Type
Grant
Description
Decode Health, alongside Circular Genomics, has announced a research initiative focused on circular RNAs in multiple sclerosis. They are leveraging Decode's NIH-funded MS biomarker program and Circular Genomics' RNA platform to enhance detection and monitoring. This collaboration aims to develop specific circRNA signatures to improve early disease detection. The initiative is anchored by a $1.9 million grant from the NIH.
Quick answer
Decode Health raised $1.9 Million in a Grant round, dated July 14, 2026. Decode Health is based in Nashville, Tennessee, United States.
- How much did Decode Health raise?
- Decode Health raised $1.9 Million in a Grant round on July 14, 2026.
- What does Decode Health do?
- Decode Health is a precision medicine R&D company based in Nashville, TN.
- Where is Decode Health based and how big is it?
- Decode Health is based in Nashville, Tennessee, United States. Fundz records about 23 employees.
Source: Fundz verified event record.
Who to call at Decode Health, and when
A new round usually means Decode Health is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Decode Health raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Decode Health, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Decode Health. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Decode Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Decode Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.